“…Unfortunately, the original study protocol failed to include measures of CS and Goldmann VF at baseline, which are stronger predictors of mobility in RP than VA 7,9,10,11 , and therefore, we can only assess mobility changes in relation to central vision changes. Comparing pre, 3 and 6 month VA, subjects 1, 2, 4 and 5 show substantial loss of VA in the treated eye and a corresponding decrease of mobility, with subject 4’s VA showing a reduction then recovery from 3 to 6 months post implant.…”